'Life-changing' once-a-day migraine pill which halves the number of crippling attacks gets green light for NHS use

A once-a-day pill could transform the lives of migraine sufferers after it was given the green light for NHS use. Atogepant will be an option for people who have at least four migraine days a month and who have tried at least three other treatments to no avail. Atogepant will be an option for people who have at least four migraine days a month and who have tried at least three other treatments to no avail It works by blocking the receptor of a protein found in the sensory nerves of the head and neck, known as the calcitonin gene-related peptide. Helen Knight, director of medicines evaluation at NICE, said: 'Currently, the most effective options for people with chronic migraines who have already tried three preventative treatments are drugs that need to be injected. Health Minister Andrew Stephenson said: 'Migraines affect millions of people in this country and this new treatment will help prevent recurring migraine attacks when other medicines have failed.